DDB2 increases radioresistance of NSCLC cells by enhancing DNA damage responses

Radiotherapy resistance is one of the major factors limiting the efficacy of radiotherapy in lung cancer patients. The extensive investigations indicate the diversity in the mechanisms underlying radioresistance. Here, we revealed that DNA damage binding protein 2 (DDB2) is a potential regulator in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Tumour Biol
Egile Nagusiak: Zou, Ning, Xie, Guozhen, Cui, Tiantian, Srivastava, Amit Kumar, Qu, Meihua, Yang, Linlin, Wei, Shaozhong, Zheng, Yanfang, Wang, Qi-En
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6528175/
https://ncbi.nlm.nih.gov/pubmed/27553023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13277-016-5203-y
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak